JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
PUT
Analog Devices
ADI
$202B
| $5.84M | ﹤0.01% |
25,600
-5,000
| -16% | -$1.07M |
2021 Q1
13 quarters
|
|
2827
O-I Glass
OI
$860M
| $5.84M | ﹤0.01% |
524,972
-342,920
| -40% | -$4.63M |
2013 Q2
44 quarters
|
|
2828
CALL
Texas Instruments
TXN
$268B
| $5.84M | ﹤0.01% |
30,000
+16,200
| +117% | +$2.99M |
2017 Q1
29 quarters
|
|
2829
Tyra Biosciences
TYRA
$1.4B
| $5.83M | ﹤0.01% |
364,751
-15,846
| -4% | -$273K |
2021 Q4
10 quarters
|
|
2830
CALL
Okta
OKTA
$37B
| $5.83M | ﹤0.01% |
62,300
-1,100
| -2% | -$104K |
2023 Q3
3 quarters
|
|
2831
PUT
DuPont de Nemours
DD
$17.6B
| $5.83M | ﹤0.01% |
57,679
+17,846
| +45% | +$1.75M |
2021 Q3
11 quarters
|
|
2832
PUT
Norwegian Cruise Line
NCLH
$6.95B
| $5.82M | ﹤0.01% |
309,800
+181,400
| +141% | +$3.18M |
2023 Q4
2 quarters
|
|
|
AHRT
2833
AH Realty Trust
AHRT
$450M
| $5.82M | ﹤0.01% |
524,453
-34,241
| -6% | -$374K |
2014 Q2
40 quarters
|
|
2834
KB Financial Group
KB
$43.5B
| $5.81M | ﹤0.01% |
102,614
+85,126
| +487% | +$4.63M |
2013 Q3
43 quarters
|
|
2835
PUT
ScottsMiracle-Gro
SMG
$2.85B
| $5.8M | ﹤0.01% |
89,200
| – | – |
2023 Q4
2 quarters
|
|
|
CPRX
2836
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.8M | ﹤0.01% |
374,373
-102,047
| -21% | -$1.59M |
2017 Q1
29 quarters
|
|
2837
Agilysys
AGYS
$2.8B
| $5.8M | ﹤0.01% |
55,670
-2,166
| -4% | -$194K |
2015 Q4
34 quarters
|
|
2838
PUT
Air Products & Chemicals
APD
$61.8B
| $5.78M | ﹤0.01% |
22,400
| – | – |
2022 Q1
9 quarters
|
|
2839
Fastly Inc
FSLY
$4.11B
| $5.78M | ﹤0.01% |
783,798
+272,342
| +53% | +$2.67M |
2019 Q4
18 quarters
|
|
2840
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.07B
| $5.76M | ﹤0.01% |
58,653
+10,588
| +22% | +$1.04M |
2017 Q4
26 quarters
|
|
2841
Rhythm Pharmaceuticals
RYTM
$6.39B
| $5.75M | ﹤0.01% |
140,146
+85,642
| +157% | +$3.42M |
2017 Q4
26 quarters
|
|
2842
Corcept Therapeutics
CORT
$12.6B
| $5.73M | ﹤0.01% |
176,497
-17,074
| -9% | -$468K |
2016 Q4
30 quarters
|
|
|
2843
PUT
Okta
OKTA
$37B
| $5.72M | ﹤0.01% |
61,100
| – | – |
2023 Q2
4 quarters
|
|
2844
Vitesse Energy
VTS
$710M
| $5.71M | ﹤0.01% |
240,908
+7,394
| +3% | +$176K |
2023 Q1
5 quarters
|
|
2845
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$304M
| $5.71M | ﹤0.01% |
127,401
+7,253
| +6% | +$329K |
2023 Q3
3 quarters
|
|
2846
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.86B
| $5.67M | ﹤0.01% |
308,839
-861,169
| -74% | -$15.7M |
2023 Q4
2 quarters
|
|
2847
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.89B
| $5.67M | ﹤0.01% |
56,685
-25,156
| -31% | -$2.51M |
2023 Q2
4 quarters
|
|
2848
Asana
ASAN
$1.97B
| $5.67M | ﹤0.01% |
405,022
+71,511
| +21% | +$1.02M |
2020 Q3
15 quarters
|
|
2849
J&J Snack Foods
JJSF
$1.46B
| $5.66M | ﹤0.01% |
34,869
-3,993
| -10% | -$611K |
2013 Q2
44 quarters
|
|
2850
Fidelity MSCI Financials Index ETF
FNCL
$2.23B
| $5.66M | ﹤0.01% |
97,627
-75,102
| -43% | -$4.35M |
2017 Q1
29 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.